Search - tctmd.com

Displaying 101 - 120 of 3616

Sort: Relevancy | Date

Presentation TCT 2016

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Usman Baber

November 01, 2016

Presentation TCT 2016

Improving Clinical Science: Priorities and Methods of Clinical Trials in Cardiovascular Regenerative Medicine

Presenter: Emerson C. Perin, Bernard J. Gersh

October 31, 2016

Presentation TCT 2016

What Are the Right Endpoints for CLI Clinical Trials?

Presenter: George L Adams, John F Angle, Patrick J. Geraghty

October 31, 2016

Presentation TCT 2016

M-Dock: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Maurice Buchbinder

October 31, 2016

Presentation TCT 2016

Caisson: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Mathew Williams

October 31, 2016

Presentation TCT 2016

Sinomed: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Maurizio Taramasso

October 31, 2016

Presentation TCT 2016

HighLife: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Ruediger S. Lange

October 31, 2016

Presentation TCT 2016

Cells Alone Work: Lessons From Recent Clinical Trials

Presenter: Emerson C. Perin

October 31, 2016

Presentation TCT 2016

Intrepid: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Vinayak Bapat

October 31, 2016

Presentation TCT 2016

Neovasc Tiara: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Anson Cheung

October 31, 2016

Presentation TCT 2016

Tendyne: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, David W.M. Muller

October 31, 2016

Presentation TCT 2016

CardiAQ: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Gian Paolo Ussia

October 31, 2016

Presentation TCT 2016

Updates on New Adjunctive Pharmacotherapy Clinical Trials for TAVR

Presenter: Raj Makkar, Lars Sondergaard, Davide Capodanno

October 31, 2016

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

Controversy 2. Global Clinical Trial Experiences on Bioprosthetic Leaflet Thickening/Thrombosis: Updates and Insights

Presenter: Raj Makkar, Lars Sondergaard

October 31, 2016

Presentation TCT 2016

Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials

Presenter: Raj Makkar, Lars Sondergaard, Samir R. Kapadia

October 31, 2016

Presentation TCT 2016

TCT 60: Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis From the ABSORB Randomized Trials

Presenter: Antonio L. Bartorelli, Kenneth Chin, Ariel Furer

October 31, 2016

Presentation TCT 2016

TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/or Multivessel Coronary Disease: A Pooled Analysis of Individual Patient Level Data From the SYNTAX, PRECOMBAT and BEST Trials

Presenter: Sorin J. Brener, Jean-François Tanguay, Rafael Cavalcante

October 31, 2016

News Industry News

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

October 31, 2016

Advertisement

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Improving Clinical Science: Priorities and Methods of Clinical Trials in Cardiovascular Regenerative Medicine

What Are the Right Endpoints for CLI Clinical Trials?

M-Dock: Design and Clinical Trial Updates

Caisson: Design and Clinical Trial Updates

Sinomed: Design and Clinical Trial Updates

HighLife: Design and Clinical Trial Updates

Cells Alone Work: Lessons From Recent Clinical Trials

Intrepid: Design and Clinical Trial Updates

Neovasc Tiara: Design and Clinical Trial Updates

Tendyne: Design and Clinical Trial Updates

CardiAQ: Design and Clinical Trial Updates

Updates on New Adjunctive Pharmacotherapy Clinical Trials for TAVR

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

Controversy 2. Global Clinical Trial Experiences on Bioprosthetic Leaflet Thickening/Thrombosis: Updates and Insights

Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials

TCT 60: Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis From the ABSORB Randomized Trials

TCT 67: Impact of the SYNTAX Score in Patients With Diabetes and Left-Main and/or Multivessel Coronary Disease: A Pooled Analysis of Individual Patient Level Data From the SYNTAX, PRECOMBAT and BEST Trials

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content